Artificial liver for severe hepatitis care
人工肝治疗重型肝炎护理

摘要

目的 研究分析重型肝炎患者人工肝治疗过程中的护理方案。方法 本次实验时间区间为2020年1月至2022年10月这一时间段，研究人员对100例重型肝炎患者进行研究。将双盲对照原则作为本次实验所选重型肝炎患者的分组依据，研究人员在参照组患者人工肝治疗过程中实施基础护理，将优质护理应用到观察组患者人工肝治疗过程中去，记录和分析比较两组患者干预前后肝功能指标、治疗依从性。结果 参照组及观察组所选患者干预前谷丙转氨酶指标、谷草转氨酶指标、总胆红素指标均无突出的差异，（p＞0.05），在干预后，两组患者肝功能指标均有着明显的改善，且观察组对应指标数据显著优于参照组，差异不容忽视，（p＜0.05）；参照组及观察组所选患者中治疗完全依从及部分依从的人数分别为43人及48人，患者治疗依从性分别为86.00%及96.00%，组间对应数据之间的差异不容忽视，（p＜0.05）。结论 在重型肝炎患者人工肝治疗过程中优质护理的应用效果显著，其临床应用价值远远高于基础护理。

Abstract

Objective To study and analyze the nursing care protocols during the artificial liver treatment for patients with heavy hepatitis.
Methods The time interval of this experiment was the time period from January 2020 to October 2022, and the researchers studied 100 patients with heavy hepatitis. The double-blind control principle was used as the basis for the grouping of patients with severe hepatitis selected for this experiment. The researchers implemented basic care during the artificial liver treatment in the reference group and applied quality care to the artificial liver treatment in the observation group, and recorded and analysed the liver function indicators and treatment compliance before and after the intervention in both groups.
Results There was no significant difference in the indexes of glutamate transaminase, glutamic oxalacetic transaminase and total bilirubin between the patients in the reference group and the patients in the observation group before the intervention (p>0.05), but after the intervention, the indexes of liver function in both groups improved significantly, and the corresponding indexes in the observation group were significantly better than those in the reference group. The number of fully and partially compliant patients in the reference group and the observation group were 43 and 48 respectively, with 86.00% and 96.00% adherence to treatment respectively.
Conclusion   The application of quality care in the treatment of artificial liver in patients with severe hepatitis is effective and its clinical application value is much higher than that of basic care.